RAFAEL
BAÑARES CAÑIZARES
Catedrático de universidad
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (50)
2023
-
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis
Hepatology (Baltimore, Md.), Vol. 77, Núm. 6, pp. 2052-2062
-
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
Cell death & disease, Vol. 14, Núm. 8, pp. 514
-
Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure
Journal of Hepatology, Vol. 79, Núm. 1, pp. 79-92
2022
-
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734
2021
-
Abnormal liver function test in patients infected with coronavirus (Sars-cov-2): A retrospective single-center study from spain
Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-18
-
Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis
Journal of Hepatology, Vol. 75, Núm. 3, pp. 589-599
-
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data
Gastroenterology, Vol. 160, Núm. 1, pp. 193-205.e10
-
Overview of virus and cancer relationships. Position paper
Revista Espanola de Quimioterapia, Vol. 34, Núm. 6, pp. 525-555
-
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
Journal of Hepatology, Vol. 74, Núm. 5, pp. 1097-1108
-
Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis
JHEP Reports, Vol. 3, Núm. 6
2020
-
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS
Journal of Hepatology, Vol. 73, Núm. 5, pp. 1082-1091
-
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
Journal of Hepatology, Vol. 73, Núm. 4, pp. 842-854
2019
-
Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH
Gastroenterologia y Hepatologia, Vol. 42, Núm. 10, pp. 657-676
-
An Accurate Data Preparation Approach for the Prediction of Mortality in ACLF Patients using the CANONIC Dataset
2019 41ST ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC)
-
An Accurate Data Preparation Approach for the Prediction of Mortality in ACLF Patients using the CANONIC Dataset
Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS
-
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
The Lancet, Vol. 393, Núm. 10181, pp. 1597-1608
2017
-
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study
Transplant International, Vol. 30, Núm. 10, pp. 1041-1050
-
Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver
Gastroenterologia y Hepatologia
2016
-
Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension
Hepatology, Vol. 63, Núm. 1, pp. 197-206
2015
-
Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy
Clinical Gastroenterology and Hepatology, Vol. 13, Núm. 10, pp. 1846-1853.e1